Tag Archives: Small Times Magazine

Pacific
Nanotechnology’s dual scanner for advanced research AFM system. (Photo: Pacific
Nanotechnology)

Mar. 5, 2007 — Pacific Nanotechnology, Inc. (PNI), provider of the tabletop Nano-R AFM systems, has released a new, dual-scanner technology platform for research applications, the Nano-DST.

The Nano-DST promises a new approach to the world of atomic force microscopy (AFM). Its large-area scanner comes in three options to study areas up to 100, 200, or 400 microns in x and y. Using flexure design and light lever detection, these scanners exhibit particularly low bow and coupling.

The second scanner is a 5 micron tube design which is embedded in a dedicated sample puck. This may be used alone or when combined with the flexure scanner, the user is able to scan a large area to locate a specific feature and then zoom in to make a high resolution image. This is of benefit to those with the most challenging AFM imaging applications

The Nano-DST claims the first SPM controller to use two x,y,z scanning control cards backed with 24 bit electronics using industry standard National Instrument cards. These advanced components enable fast scanning where collection of a 300 line image is made in one second.

Mar. 5, 2007 — Arrowhead Research Corp.(ARWR) says its majority-owned subsidiary Insert Therapeutics has signed a definitive agreement with R&D Biopharmaceuticals to acquire an exclusive, world-wide license to multiple second generation epothilone anticancer drugs. Insert will apply its proprietary Cyclosert transport system to select second generation epothilones now in development at R&D.

Epothilones, despite their promise as potent anti-cancer drugs, have encountered clinical difficulties due to their toxic side effects in patients. Cyclosert is the first nanoparticle drug transport platform to be designed de novo and synthesized specifically to overcome limitations in existing technologies used for the systemic transport of therapeutics to targeted sites within the body.

Based on small cyclic repeating molecules of glucose called cyclodextrins, its application to these second generation epothilone drugs are expected to promote their ability to inhibit the growth of human cancer cells while remaining non-toxic and non-immunogenic at therapeutic doses. In particular, the system is designed to keep the drugs non-toxic until they actually reach the targeted tumor cells where active drug is released in a controlled fashion.

“This is a significant step for both Insert Therapeutics and cancer care delivery in general,” said Edward Jacobs, Chief Executive Officer and President of Insert Therapeutics. “We hope this collaboration will allow a broader range of cancer patients to realize a potentially greater therapeutic effect from potent cancer drugs that may otherwise have been too toxic for them to receive.”

“We are excited about this strategic partnership with R&D-Biopharmaceuticals,” said R. Bruce Stewart, Chairman of Arrowhead. “We expect to continue to enhance the overall effectiveness of cancer treatment with other therapeutic candidates in the future.” “The combination of the Cyclosert technology has already demonstrated impressive effectiveness with other cytotoxics”, Wolfgang Richter, Managing Director of R&D-Biopharmaceuticals added.
“The collaboration with Insert Therapeutics is expected to fully leverage the potential of the new second generation epothilones.”

Epothilones are naturally occurring microtubule depolymerisation inhibitors, which stop the growth of human cancer cells in vitro at nano or even subnanomolar concentrations. Their attractive preclinical profile has made epothilones important lead structures in the search for improved cytotoxic anticancer drugs. R&D will use its proprietary know-how to synthesize novel and proprietary epothilone derivates, whose pharmaceutical profile will be evaluated in the relevant testing systems. Promising candidates showing the best profile will be considered for full preclinical development.

First generation epothilones are in clinical development by numerous pharmaceutical companies. Among the aims of second generation epothilone development is to optimize them for biological selectivity, stability, and water solubility. All of these properties have been shown to be effectively enhanced in other cytotoxic agents by use of the Cyclosert transport system. The combination of a second generation epothilone with Cyclosert should be highly competitive in this crowded field.

To receive a copy of the 2007 Small Times University Survey please email Thomas Markley or call 603-891-9307.

For questions regarding the content of the survey – please email Barbara Goode or call 603-891-9194.

The May/June 2007 issue of Small Times will feature the university survey results, as well as an index listing each university that responds to the attached survey.

We would like to include your university, but we will need your assistance. Please take the time to fill out the survey in as complete detail as possible.

Note: This year there are two versions of the survey. The first version of the survey – the University Rankings Survey is for large, global research universities. Our Technical College Survey is for all smaller teaching universities and colleges that are offering micro or nanotechnology focused training and education programs.

Mar 2, 2007 — Samsung Electronics has begun mass-producing what it calls the industry’s first 1Gigabit DDR2 DRAM chip using 60 nanometer-class process technology. The company says this sets it apart from competitors still using 80-nanometer technology.

Samsung, said to be the word’s largest maker of memory chips, says the new process can increase production efficiency by 40 percent over the 80-nanometer technology that has been deployed in dynamic random access memory (DRAM) chip manufacturing since last year. The firm anticipates that improved productivity will cut costs and help 60-nano 1 gigabit DRAM chips become a mainstream item in 2008.

Samsung says the 60nm 1Gb DDR2 DRAM, which it first developed in 2005, is the latest in a long line of Samsung industry “firsts” in nano-scale DRAM advancements. The company expects that the 60-nano DRAM revenue will reach $2.3 billion worldwide this year, and $32 billion by 2009.

Capistrano Light luggage uses nanotechnology to provide protection against stains and elements. (Photo: Ricardo Beverly Hills)

Mar. 2, 2007 — Ricardo Beverly Hills, of Mirada, Calif., claims a first in the luggage industry: the use of nanotechnology integrated into suitcases and bags. The Capistrano Light Luggage Line features lightweight Nano-Tex treated fabric, which uses nanotechnology to “provide superior protection against stains and outdoor elements.” The result: luggage that stays cleaner and maintains a new look even after use.

“After a great deal of research and testing, we identified the usage of nanotechnology as the key to creating lightweight fabric that provides superior protection against stains and other elements,” said Robert Dodson, President of Ricardo Beverly Hills. “We selected Nano-Tex fabric and the end result is beautiful luggage that will withstand the test of time.”
In 2006, Ricardo Beverly Hills was honored by the Travel Goods Association as Product Innovation Award Winner for its luggage collection that weighs itself with a built-in digital scale to help travelers avoid airline overweight luggage penalties.

“Our company has a long history of creating innovative products that are designed to advance the luggage industry as a whole and deliver solutions to consumers,” Dodson added.


Nano-piezotronics uses piezoelectric and semiconducting properties to produce novel components. (Photo: Georgia Tech)

Mar. 1, 2007&#8212Researchers at the Georgia Institute of Technology have taken advantage of the unique coupled semiconducting and piezoelectric properties of zinc oxide nanowires to create a new class of electronic components and devices that could provide the foundation for a broad range of new applications.

So far, the researchers have demonstrated field-effect transistors, diodes, sensors, and current-producing nanogenerators¿that operate by bending zinc oxide nanowires and nanobelts. The new components take advantage of the relationship between the mechanical and electronic coupled behavior of piezoelectric nanomaterials, a mechanism the researchers call “nano-piezotronics.”

“Nano-piezotronics utilizes the coupling of piezoelectric and semiconducting properties to fabricate novel electronic components,” said Zhong Lin Wang, a Regents Professor in the School of Materials Science and Engineering. “These devices could provide the fundamental building blocks that would allow us to create a new area of electronics.”

For example, in a nano-piezotronic transistor, bending a one-dimensional zinc oxide nanostructure alters the distribution of electrical charges, providing control over the current flowing through it. By measuring changes in current flow through them, piezotronic sensors can detect forces in the nano- or even pico-Newton range. Other piezotronic sensors can determine blood pressure within the body by measuring the current flowing through the nanostructures. And, an electrical connection made to one side of a bent zinc oxide nanostructure creates a piezotronic diode that limits current flow to one direction.

The nano-piezotronic mechanism takes advantage of the fundamental property of nanowires or nanobelts made from piezoelectric materials: bending the structures creates a charge separation – positive on one side and negative on the other. The connection between bending and charge creation has also been used to create nanogenerators that produce measurable electrical currents when an array of zinc oxide nanowires is bent and then released.

Development of a piezotronic gated diode based on zinc oxide nanowires was reported February 13 in the online advance issue of the journal Advanced Materials. Other nano-piezotronic components have been reported in the journals Nano Letters and Science. The research has been sponsored by the National Science Foundation (NSF), Defense Advanced Research Projects Agency (DARPA), the National Institutes of Health (NHI) and NASA.

“The future of nanotechnology research is in building integrated nanosystems from individual components,” said Wang. “Piezotronic components based on zinc oxide nanowires and nanobelts have several important advantages that will help make such integrated nanosystems possible.”

These advantages include:

* Zinc oxide nanostructures can tolerate large amounts of deformation without damage, allowing their use in flexible electronics such folding power sources.
* The large amount or deformation permits a large volume density of power output.
* Zinc oxide materials are biocompatible, allowing their use in the body without toxic effects.
* The flexible polymer substrate used in nanogenerators would allow implanted devices to conform to internal structures in the body.
* Nanogenerators based on the structures could directly produce power for use in implantable systems.

In comparison to conventional electronic components, the nano-piezotronic devices operate much differently and exhibit unique characteristics. In conventional field-effect transistors, for instance, an electrical potential – called the gate voltage – is applied to create an electrical field that controls the flow of current between the device’s source and its drain. In the piezotronic transistors developed by Wang and his research team, the current flow is controlled by changing the conductance of the nanostructure by bending it between the source and drain electrodes. The bending produces a “gate” potential across the nanowire, and the resulting conductance is directly related to the degree of bending applied.

“The effect is to reduce the width of the channel to carry the current, so you can have a 10-fold difference in the conductivity before and after the bending,” Wang explained.

Diodes, which restrict the flow of current to one direction, have also been created through nano-piezotronic mechanisms to take advantage of a potential barrier created at the interface between the electrode and the tensile (stretched) side of the nanowire by mechanical bending. The potential barrier created by the piezoelectric effect limits the follow of current to one direction.

Nanogenerators, which were announced in the April 14, 2006 issue of the journal Science, harvest energy from the environment around them, converting mechanical energy from body movement, muscle stretching, fluid flow or other sources into electricity. By producing current from the bending and releasing of zinc oxide nanowires, these devices could eliminate the need for batteries or other bulky sources for powering nanometer-scale systems.

Piezotronic nanosensors can measure nano-Newton (10 -9) forces by examining the shape of the structure under pressure. Implantable sensors based on the principle could continuously measure blood pressure inside the body and relay the information wirelessly to an external device similar to a watch, Wang said. The device could be powered by a nanogenerator harvesting energy from blood flow.

Other nanosensors can detect very low levels of specific compounds by measuring the current change created when molecules of the target are adsorbed to the nanostructure’s surface. “Utilizing this kind of device, you could potentially sense a single molecule because the surface area-to-volume ratio is so high,” Wang said.

Mar. 1, 2007 — Malvern Instruments‘s Zetasizer nano particle and molecular characterisation system now offers a chromatography flow-mode option that lets the system operate as an in-line chromatography detector. The new option allows the coupling of dynamic light scattering with size exclusion chromatography, enabling Absolute Size Exclusion Chromatography (ASEC). This means protein size can be measured directly rather than indirectly through column calibration or additional data from a second detector. It also means that molecular weight standards are no longer required to identify oligomeric species or determine protein purity.

The instrument can be added to any SEC set-up; no column calibration is required and Malvern promises that its software makes the measurement process easy.

By Serge Zinger and Yuji Kurono, Panasonic Electric Works

MEMS technology has been used to gain significant improvements in a number of electronic and industrial applications, but until recently, the area of electronic circuitry has been neglected. Often seen as mature product, printed circuit board layouts can now be projected onto a 3D substrate to form miniaturized circuits, with unique attributes.

Panasonic Electric Works’ new MIPTEC (Microscopic Integrated Processing Technology) allows the formation of a three-dimensional printed circuit board on an injection-molded substrate using fine-pitch laser patterning, giving excellent thermal and electrical properties. This approach enables miniaturization of a module, while increasing the functionality of the device.

MIPTEC uses molded 3D substrates to allow components to be mounted at any angle without using a flexible circuit board, thus improving the stability of the component – especially important when using MEMS sensors such as an acceleration or motion sensor. Since many modules require the precise relative positioning of two or more components, such as an emitter and detector, the ability to reliably locate components relative to each other improves signal strength and reliability.

Click here to enlarge image

In addition, the MIPTEC technology can utilize a range of substrate materials to provide the optimal thermal or optical characteristics.

In the case of LED or laser packaging, efficient heat removal from the component can be critical to the performance of the device; using a substrate with high thermal conductivity reduces the operating temperature of the LED package, thus increasing both the brightness and the lifetime of the device.

Proprietary laser patterning technology

MIPTEC brings together a number of related technologies to be able to create the 3D circuitry – notably a proprietary laser patterning technology, unique surface activation processing and the use of novel materials, all applied to standard Molded Interconnect Device (MID) technology. This combination of techniques is used to achieve the compactness and high functionality of equipment and modules not possible with the conventional process.

The key enabling technology is the proprietary laser patterning technique which can be used to form an extremely fine-pattern electrical circuit on six molded surfaces with a laser beam. The minimum width of line/space is 70µm/70µm that supports the miniaturization of devices or modules, and is about one-third the width of the conventional process.

The position image recognition of individual elements maintains a high patterning accuracy. Pattern forming accuracy is ±30µm between each element, allowing for high performance and high reliability of products and modules. The pattern design can easily be modified through the software interface. With the conventional process of three-dimensional MID, two sets of molds are required (one for component shape and one for pattern design) with a new mold required if pattern design changes. With the MIPTEC process, only one set of molds is needed.

Click here to enlarge image

Surface activation processing technology allows mounting of a variety of components, including bare chips. Combined with the use of advanced materials, this provides extra pattern surface smoothness and strong adhesion of the circuit pattern, enabling stable flip-chip placement and wire-bonding of bare chips. With a conventional chemical process, Rz is about 18µm, and adhesion is achieved by the anchoring effect. With the MIPTEC process, on the other hand, Rz is about 2.8µm, which makes it is easy to form a micro-pattern circuit, and has the additional benefit of forming an optically reflecting surface.

Ceramic material can be used in the MIPTEC process, and it is particularly suited for applications requiring heat dissipation, prevention of thermal deformation and high-frequency characteristics. Ceramic MIPTEC delivers both stable ceramic properties and pattern accuracy from the process of injection molding, sintering, and pattern forming.

Manufacturing technology

Panasonic’s MIPTEC manufacturing process, called “one-shot laser-structuring method,” consists of four major stages: (1) molding, (2) circuit forming, (3) plating, and (4) cutting.

The first stage has two steps: injection-molding and surface activation treatment. The intended shape is injection-molded in a sheet form containing multiple units for production purposes. Then, surface activation treatment is applied to smooth out the surface and to increase adhesion of the conductor.

The second stage, known as circuit forming, incorporates two steps: metallization and patterning. Thin copper film is formed in the base metallization process. A laser is then used to remove copper and outline the circuit pattern, with the wavelength and exposure time of the laser optimized to achieve copper removal without damaging the substrate. With a dynamic focus function, the laser focus position is controlled to remove a constant width of copper regardless of the angle of the sloped surface.

Click here to enlarge image

The plating stage consists of three steps: electric copper plating, soft etching, and electric nickel and gold plating. First, copper is electrically plated to form the circuit pattern. Then, soft etching is applied to remove unnecessary copper that was not removed by the laser in the previous stage. Finally, nickel and gold are plated on the copper to help prevent oxidation and corrosion.

In the final cutting stage, the sheet form is diced into individual pieces.

Optimizing performance of the miniaturized package

A series of simulation techniques have been developed to support MIPTEC applications as needed. To optimize the circuitry design and, ultimately, the package performance, a wide variety of analyses can be applied to the process.

Optical analysis, which includes optical intensity and beam distribution analysis, is used for the purpose of developing package designs with the best possible reflective properties. Thermal analysis, including conductivity characteristics, can be related to the performance reliability and lifetime analysis of MIPTEC devices.

By analyzing the flow of resin, the injection process can be optimized and the weld-line position identified, while the fiber orientation analysis determines thermal deformation and expansion/shrinkage tendency. Finally, analysis of stress in the solder joints, which can be caused by a difference in the coefficient of thermal expansion, helps improve package reliability.

Applications of MIPTEC

3D circuitry formed by MIPTEC can be used in a wide range of applications, each of which relies on one or more of the unique benefits of the technology.

For example, LED packages can have higher efficiency by incorporating a reflective surface; in this case, a carefully controlled silver plating procedure can be incorporated into the MIPTEC process to maximize reflector efficiency and anti-corrosion performance. By controlling the size of crystals in the plating, the reflectivity of the surface can be optimized. For example, a grain size of approximately 3µm may give a reflectivity of 94% at 475µm; compared to 92% with a 1µm grain size.

Careful control of the surface morphology can also be used to reduce corrosion of the material and to prevent solder creep.

Flip-chip packaging is also made possible by the selection of a molding material with a low coefficient of thermal expansion to minimize anisotropy, to reduce the stress load on the adhesive used to secure the gold bumps. Tests show that the connecting resistance on a typical IC chip with gold bumps is reduced from 50mW to 35mW using the anisotropic process, thus increasing the reliability of the package.

MIPTEC technology can been applied to a wide range of miniaturized devices, including the integration of an LED chip and image sensor into a single module for a cell-phone camera; the combination of components in a behind-the-ear hearing aid to eliminate the need for multiple flexible boards; and the placement of an acceleration sensor at an angle within a module to detect tilt. Over the last three years, Panasonic has used MIPTEC to manufacture some of its products. For example, MIPTEC was used to integrate an ASIC chip, image sensor, and amplifier into a miniaturized motion sensor, reducing the overall package size by a factor of 10 from its original design.

This new three-dimensional circuitry will enable the development of any number of devices that require flexibility, miniaturization, and optimal electrical and thermal properties, and is another step in the widespread adoption of micro-technology manufacturing.

Serge Zinger is engineering manager in the technical marketing division, and Yuji Kurono is project engineer, both at Panasonic Electric Works Corp. of America (pewa.panasonic.com). For more information, contact [email protected].

R&D UPDATES


March 1, 2007

Technique quickly identifies bacteria for food safety

Researchers at Purdue University have used a new technique to rapidly detect and identify bacteria, including dangerous E. coli, without the time-consuming treatments usually required.

The technique, called desorption electrospray ionization, or DESI, could be used to create a new class of fast, accurate detectors for applications ranging from food safety to homeland security, says R. Graham Cooks, the Henry Bohn Hass Distinguished Professor of Chemistry in Purdue’s College of Science.

Using a mass spectrometer to analyze bacteria and other microorganisms ordinarily takes several hours and requires that samples be specially treated and prepared in a lengthy series of steps. DESI eliminates the pretreatment steps, enabling researchers to take “fingerprints” of bacteria in less than a minute using a mass spectrometer.

“This is the first time we’ve been able to chemically analyze and accurately identify the type of bacteria using a mass spectrometer, without any prior pretreatment, within a matter of seconds,” says Cooks.

New findings show how the Purdue researchers used the method to detect living, untreated bacteria, including E. coli and Salmonella typhimurium, both of which cause potentially fatal infections in humans.


This illustration depicts the use of a technique developed at Purdue to identify bacteria in its ambient environment using mass spectrometry. The technique, called desorption electrospray ionization, or DESI, could be used to create a new class of fast, accurate detectors for applications ranging from food safety to homeland security. Image courtesy of Purdue University
Click here to enlarge image

“There is always an advantage to the analysis of living systems because the bacteria retain their original properties,” says Cooks.

The findings are detailed in a paper appearing January 7 in the journal Chemical Communications. The paper was written by chemistry graduate students Yishu Song, Nari Talaty and Zhengzheng Pan; Andy W. Tao, an assistant professor of biochemistry; and Cooks.

Mass spectrometry works by turning molecules into ions, or electrically charged versions of themselves, inside the instrument’s vacuum chamber. Once ionized, the molecules can be more easily manipulated, detected, and analyzed based on their masses. The key DESI innovation is performing the ionization step in the air or directly on surfaces outside of the mass spectrometer’s vacuum chamber. When combined with portable mass spectrometers also under development at Purdue, DESI promises to provide a new class of compact detectors.

Purdue researchers are focusing on three potential applications for detecting and identifying pathogens: food safety, medical analysis, and homeland security. Such a detector could quickly analyze foods, medical cultures and the air in hospitals, subway stations and airports, Cooks says.

The researchers are able to detect one nanogram, or a billionth of a gram, of a particular bacterium. More importantly, the method enables researchers to identify a particular bacterium down to its subspecies, a level of accuracy needed to detect and track infectious pathogens. The identifications are based on specific chemical compounds, called lipids and fatty acids, in the bacteria.

“We can determine the subspecies and glean other information by looking at the pattern of chemicals making up the pathogen, a sort of fingerprint revealed by mass spectrometry,” claims Cooks. “Conventional wisdom says quick methods such as ours will not be highly chemically or biologically specific, but we have proven that this technique is extremely accurate.”

The procedure involves spraying water in the presence of an electric field, causing water molecules to become positively charged hydronium ions, which contain an extra proton. When the positively charged droplets come into contact with the sample being tested, the hydronium ions transfer their extra proton to molecules in the sample, turning them into ions. The ionized molecules are then vacuumed from the surface into the mass spectrometer, where the masses of the ions are measured and the material analyzed.

Such a system could alert employees in the food and health-care industries to the presence of pathogens and could provide security personnel with a new tool for screening suspicious suitcases or packages.

Song will further the research, conducting experiments to look for bacterial contaminants in foods. Ongoing work by Talaty with international E. coli expert Barry Wanner, a professor in Purdue’s Department of Biological Sciences, will apply the method to living bacteria in so-called biofilms.

DESI has been commercialized by Indianapolis-based Prosolia Inc.
– Emil Venere


Company develops 50V CMOS process with embedded flash

Austriamicrosystems’ foundry business unit announced a 50V High-Voltage CMOS process with embedded Flash. The company says this is the consequent next step in extending austriamicrosystems’ position in High-Voltage CMOS technology.

The new Flash process technology is, like the High-Voltage CMOS technology, a modular extension of austriamicrosystems’ 0.35µm CMOS process. Complete compatibility to the base process allows re-use of IP Blocks and adding Flash memory to it on a single chip. The company says its High-Voltage CMOS process is suited for harsh environment, making it ideal for designs in power management, automotive or medical applications.


Draper inertial stellar compass fully operational

Draper Laboratory in Cambridge, Mass., announced that its Inertial Stellar Compass (ISC) is now fully operational on board the TacSat-2 spacecraft, representing the first use of a MEMS gyro in a complete spacecraft attitude determination system.

TacSat-2 was launched on December 16 from Wallops Flight Facility. Following basic spacecraft commissioning activities, the ISC was first turned on December 27, and two days of preliminary functional tests show the instrument to be working perfectly.


Draper Laboratory’s Inertial Stellar Compass (ISC) is now fully operational on board the TacSat-2 spacecraft. Photo courtesy of Draper Laboratory
Click here to enlarge image

The ISC combines a star camera and MEMS gyros with a microprocessor to provide a full 3-axis attitude determination system in a low power (3.6W) and low-mass (2.9kg) package, less than one-half the power and mass of conventional systems. It was developed at Draper Laboratory and uses Draper’s MEMS Tuning Fork Gyro package.

The lab says the fully autonomous, self-initializing instrument has operated flawlessly since being powered up on Dec. 27. Requiring no more than power and an occasional clock update from the host spacecraft, the ISC initializes upon startup, acquires and identifies stars from its own star catalog, and uses its “lost-in-space” algorithms to determine the direction in which it is pointing. If all continues to go well aboard the TacSat-2 spacecraft, a series of dedicated tests are planned for the coming weeks that will acquire extensive data to verify ISC performance under a wide variety of conditions.

The ISC development was funded by NASA’s New Millennium Program (NMP), which is managed by the Jet Propulsion Laboratory in Pasadena, Calif. The TacSat-2 spacecraft was developed by the Air Force Research Laboratory (AFRL) and is operated out of the AFRL command center at Kirtland AFB in Albuquerque, N.M.


NanoSensors initiates first prototype production of product to detect E. coli

NanoSensors Inc., a Santa Clara, Calif., nanotechnology development company that develops instruments and sensors to detect explosives and chemical and biological agents, announced that it has engaged a third-party contractor to manufacture units of a test version of its biosensor product that will be used for third-party field testing.

The company expects to receive delivery of the product units and commence testing during the first quarter of 2007 in order to obtain feedback on the performance of the biosensor. The product is based on the company’s recently licensed nanoporous silicon-based biosensor technology to detect E. coli.

Although NanoSensors has not entered into testing agreements with third parties, it is seeking to enroll between 6 and 10 users in its product testing program in order to subject the product design to simulated field conditions and to further assess the commercial viability of the current design. It is expected that the testing cycle will continue for a period of approximately three months and the company intends to deploy the biosensors in a number of different testing conditions. After the testing period is complete, the company said it intends to incorporate user feedback into the product design in order to improve product functionality, as may be appropriate.

The proposed biosensor has been designed to consist of two core functional parts: a disposable housing unit in which the actual sensor device is mounted and a separate, external data acquisition unit.

Based on this design, the disposable housing unit that contains the sensor transmits signals across electrical leads to the data acquisition unit, which accepts the output signal from the disposable housing unit and converts the signal to the appropriate format to display the results.


Carbon nanotubes provide critical link to block HIV

Researchers led by Hongjie Dai at Stanford University are using carbon nanotubes to solve the challenge of efficient and targeted delivery of RNA into cells. Solving the problem promises a new type of gene therapy that involves binding short DNA fragments (interfering RNA) to specific genes to block their “translation” into the corresponding, disease-related protein.

The use of carbon nanotubes has allowed the researchers to successfully introduce RNA fragments that “switch off” the genes for special HIV-specific receptors and co-receptors on the cells’ surface into human T-cells and primary blood cells. This leaves few entry points for the HIV viruses. The researchers report in the journal Angewandte Chemie that this allows for much better silencing effect to the cells than current transport systems based on liposomes.

T-cells are one of the types of white blood cells important for a good immune defense; they detect and destroy virus-affected cells. However, they themselves are among the targets attacked by HIV. In order to enter into a T-cell, the virus must first dock to a receptor known as CD4. Also involved is the co-receptor CXCR4. The use of short interfering RNA strands allows the CD4 and CXCR4 genes of the T-cell to be shut off. The T-cell then strops producing these receptors and the virus cannot find any points of attack on the surface of the cell. This could significantly slow down an HIV infection, as previous work has shown.

But how to get the RNA fragments into the T-cells? The shells of nonpathogenic viruses can be used to smuggle genetic material into cells, but this is dangerous in therapeutic applications because they can trigger allergies. Liposomes, tiny bubbles of fat, are safe but have proven to be ineffective for use in T-cells.

Carbon nanotubes are known for their abilities to be absorbed by cells and to smuggle in other molecules at the same time. The researchers attached phospholipids-molecules from which cell membranes are also made-to chains of polyethylene glycol. The phospholipids nestle securely onto the outer wall of the carbon nanotubes while the polyethylene glycol chains protrude into the surrounding solution.

The required RNA molecules were fastened to the ends of these chains. Once inside the cell, the RNA could easily be split off by means of a sulfur-sulfur bridge.


EPA issues nanotechnology White Paper

The Environmental Protection Agency has issued its Nanotechnology White Paper, EPA 100/B-07/001, to inform EPA’s management of the science issues and needs associated with nanotechnology, to support related EPA program office needs, and to communicate the identified nanotechnology science issues to stakeholders and the public.

The white paper provides background information regarding nanotechnology and various environmental issues and discusses the risk assessment of nanomaterials, the environmentally responsible development of nanoscale materials, and the EPA’s research needs regarding nanomaterials.


Nanoparticles shed light on disease-causing proteins

The problem with current protein profiling methods is that the small samples are so sensitive that “we can’t effectively use existing technologies to study them,” says Andy Tao, a Purdue University biochemist. In an effort to discover a better way to ascertain the presence, concentration, and function of proteins involved in disease processes, Tao and his colleagues bound a complex nanomolecule, called a dendrimer, with a glowing identification tag delivered to specific proteins in living venom cells from a rattlesnake.

The researchers hope the new method will also facilitate better, more-efficient diagnosis in living cells and patients. Because molecular interactions and protein functions are disturbed when samples are collected, researchers can’t obtain an accurate picture of biochemical mechanisms related to illnesses such as cancer and heart disease.


Andy Tao uses a linear ion trap mass spectrometer to analyze several hundred proteins per hour. Photo courtesy Purdue Agricultural Communication/Tom Campbell
Click here to enlarge image

Tao and his research team used dendrimers because they can pass through cell walls efficiently with little disturbance to the cells and then label specific proteins with isotopic tags while cells are still alive. This allows the scientists to determine the activities of proteins that play roles in specific diseases. Proteins carry genetic messages throughout the cell causing biochemical changes that can determine whether a cell behaves normally or abnormally. Proteins are also important in directing immune responses.

The team, which includes Purdue postdoctoral student Minjie Guo and Purdue graduate student Jacob Galan, report on their new strategy to discover proteins and protein levels, called soluble polymer-based isotopic labeling (SoPIL), in the current issue of the journal Chemical Communications. The study is also featured in the journal’s news publication Chemical Biology.

The dendrimers would carry one of the stable isotopic or fluorescent labels to identify the presence or absence of a protein that can be further developed for use as a disease indicator, or biomarker.

Snake venom cells were used because they have a very high concentration of proteins similar to some found in human blood, Tao says. The proteins apparently are part of the biochemical process that affects blood clotting or hemorrhage. Understanding how the proteins behave could help determine predisposition to heart disease and cancer and also be useful in diagnosis and drug development.

In future research, Tao plans to investigate how dendrimers are able to enter the cell so easily, what happens to them once they are in the cell, and whether there are any long-term effects.


Molecular memory breakthrough using nanowires

A team of UCLA and California Institute of Technology chemists reported in the January 25 issue of the journal, Nature, the successful demonstration of a large-scale, “ultra-dense” memory device that stores information using reconfigurable molecular switches. This research represents an important step toward the creation of molecular computers that are much smaller and could be more powerful than today’s silicon-based computers. The 160-kilobit memory device uses interlocked molecules manufactured in the UCLA laboratory of J. Fraser Stoddart, director of the California NanoSystems Institute (CNSI).

Scientific progress is a balancing act: Weigh the empirical evidence and determine the appropriate balance between allowing new technologies and protecting public health.

Often, especially where there is little opportunity for sensationalizing the technology and its impact, risk analysts and managers can do their vital work in relative quiet and make sound and defensible decisions.

However, every now and then development is stymied by fear, which can overwhelm promising physical data. That was the story of the years-long public debate over agricultural biotechnology. In the wake of the FDA’s recent public meetings on the regulation of nanotechnology, nanotech is now poised on the same knife’s edge as biotech was in the last decade.

For several years, we have been hearing about nanotechnology’s potential benefits. As with all new technologies, the bright promise of potential breakthroughs attracts investment and publicity at the same time that it is accompanied by a stream of warnings about the need for caution (or, in some quarters, precaution).

In the United States the FDA held a broad-based public meeting for stakeholders in October 2006 to more closely examine the issue and to allow consumers, scientists, industry and other interested parties to weigh in. In January, it held an additional meeting and began soliciting input to develop priorities for environmental health and safety efforts.

The October meeting began with a series of well-presented speeches and testimony from a variety of stakeholders. The message from the scientists was unmistakable: The technology is a series of varied and remarkable applications that hold incalculable promise and which, like any applications, require appropriate partnerships between industry and government to determine risk.

But as the consumer activist community began its presentations, the message transmuted into one of fear and risk, focusing on the “lack of urgency and resources.” The FDA’s approach came out badly in comparison to the precautionary principle (unsafe unless proven safe, and conclusively) approach that characterizes the European Union’s approach to regulation.

If this view holds, it will be a pity. Nanotechnology gives regulators the chance to get it right the first time, rather than succumb to the pressures to regulate based on an intellectually dishonest commingling of risk and hazard.

The FDA’s efforts have been described as a logical next step in a continuum of efforts to ensure the consuming public – and the industries that will be offered more and more nanomaterials and nanoapplications for their finished products – that regulators understand the importance of “getting it right” and regulating based on realistic risk assessment.

This is in contrast to the troubling pattern of recent years where governments, bowing to concerns expressed by some activist groups, have conflated risk and hazard and stigmatized entire industries, preferring to use murky “precautionary principles” to regulate based on means of production, rather than on the safety of the product.

E. coli is a hazard to human life that must be eradicated. But nanomaterials should not be inappropriately classified as a similar hazard. If left unregulated, they could pose a risk, but if nanomaterials are managed carefully consumers can derive the tremendous benefits that accompany the understandable risk. There is a big difference, and the future depends on government’s ability to understand it and to regulate and communicate accordingly.

There is no reason misunderstanding should occur. The United States has robust regulatory systems in place that allow each application to be evaluated and assessed on its own merits, though proper funding of those regulatory agencies would be of inestimable assistance.

The FDA has a golden opportunity to turn a bad trend on its head and show the world that regulation based on empirical data, rather than on fear, provides the best hope for a safe future. At the same time, it can bring home the truth that regulating the fruits of innovative technology based on uninformed fears imposes on society an unacceptable opportunity cost.

The message that ultimately emerges will influence what regulators around the world decide to do. An exercise of confident, sure-footed control by the FDA will go a long way toward building public confidence in an area where perceptions have yet to become rooted.

Click here to enlarge image

Mark Mansour is a partner with Foley & Lardner LLP, where he is a member of the nanotechnology industry team, and public affairs and international practices. He can be reached at [email protected].